RRAS2 and breast carcinoma: To study if RRAS2 overexpression could also be a driver oncogene in the development of human breast cancer, we collected a total of n = 397 human breast cancer samples from two biobanks in Spain (AHSB and FIVO) and analyzed RRAS2 overexpression (Table 3).